breast cancer chemo before surgery

Release time ：Dec-18,2024

Preoperative chemotherapy for breast cancer is a widely utilized treatment approach designed to reduce tumor size and enhance the likelihood of successful surgery. It is typically indicated for patients with larger tumors or those presenting high-risk factors. By administering chemotherapy prior to surgery, the response of the tumor to medication can be evaluated, aiding physicians in devising a more accurate surgical plan.

The advantages of preoperative chemotherapy encompass, but are not limited to: firstly, it can downgrade the clinical stage of the tumor, offering patients who might have required mastectomy the possibility of breast-conserving surgery. Secondly, for tumors that are challenging to definitively diagnose via imaging, preoperative chemotherapy assists doctors in assessing the malignancy and invasiveness of the tumor. Furthermore, preoperative chemotherapy can mitigate the risk of tumor cell dissemination during surgery, thus lowering the potential for postoperative recurrence.

However, preoperative chemotherapy is not without its limitations and risks. Some patients may exhibit resistance to chemotherapeutic agents, resulting in suboptimal tumor reduction. Additionally, chemotherapy drugs can induce a range of side effects, such as nausea, vomiting, and hair loss, which can impact the patient's quality of life. Consequently, when deciding on the implementation of preoperative chemotherapy, physicians take into account a variety of factors including the patient's condition, physical health, and personal preferences.

For patients diagnosed with breast cancer, timely medical consultation and adherence to the physician's treatment recommendations are of paramount importance. Before initiating any treatment, it is imperative for patients to thoroughly understand their condition and the pros and cons of various treatment options to make the most informed decision. Patients should also maintain a positive attitude, actively engage in treatment, and regularly participate in follow-up and surveillance to optimize treatment outcomes and survival rates.